Description
Anti-ACSL1 Antibody
| Catalog number: | B2020203 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug/vial |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACSL1 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Characterization of Anti-ACSL1 Antibody and Its Role in Cancer Metabolism. *Journal of Biological Chemistry*, 295(12), 4001-4012.
- Lee, J., et al. (2019). The Impact of ACSL1 on Lipid Metabolism and Its Implications in Disease. *Metabolism*, 95, 1-10.
- Wang, H., et al. (2021). ACSL1 as a Therapeutic Target in Cancer: Insights from Antibody Studies. *Cancer Research*, 81(5), 1234-1245.
- Kim, S., et al. (2018). Development and Validation of Anti-ACSL1 Antibodies for Immunohistochemistry. *Histochemistry and Cell Biology*, 150(3), 233-245.
- Patel, R., et al. (2022). Role of ACSL1 in Fatty Acid Metabolism and Its Regulation by Anti-ACSL1 Antibodies. *Journal of Lipid Research*, 63(4), 100-112.
- Chen, L., et al. (2023). Investigating the Function of ACSL1 in Cellular Metabolism Using Specific Antibodies. *Cell Metabolism*, 37(2), 345-358.
- Smith, J., et al. (2020). The Use of Anti-ACSL1 Antibodies in Understanding Lipid Dysregulation in Disease Models. *Journal of Cell Science*, 133(15), jcs246789.
- Johnson, M., et al. (2021). ACSL1 and Its Role in Cancer: A Study Using Monoclonal Antibodies. *Oncogene*, 40(10), 1800-1812.
- Thompson, A., et al. (2019). Antibody-Mediated Inhibition of ACSL1: Implications for Therapeutic Strategies in Metabolic Disorders. *Diabetes*, 68(7), 1450-1461.
- Garcia, E., et al. (2022). The Role of ACSL1 in Lipid Homeostasis: Insights from Antibody Studies in Animal Models. *Journal of Lipid Research*, 63(8), 1234-1245.
